November 10, 2022 — A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding ...
November 10, 2022 — Researchers at the University of Maryland School of Medicine’s (UMSOM) Center for Precision Disease ...
November 10, 2022 – Significant findings from the clinical trial, known as “BEST-CLI — Best Endovascular versus Best ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
November 9, 2022 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), left ...
November 9, 2022 — Lexicon Pharmaceuticals, Inc. announced that a new analysis of results from the SOLOIST-WHF Phase 3 ...
November 9, 2022 — CinCor Pharma, Inc. announced the presentation today of Phase 2 data from its BrigHtn trial as part ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The world market for interventional X-ray and mobile C-arm equipment is forecast to reach over $4.9 billion by 2026 ...
November 9, 2022 — Seven awardees were honored during the American Heart Association Scientific Sessions (AHA 2022). The ...
Interventional cardiologists know well the phrase “change is the only constant.” This is especially relevant as ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Numerous indicators make clear that the next five years will usher in extreme transformation for a multitude of ...
Reflecting back, 2022 has been a productive year. It brought with it many changes and challenges, but also brought back ...
November 8, 2022 — Genomic-based therapies for cardiovascular disease are emerging fast in research, and could soon be ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 8, 2022 — After hospital discharge for heart failure, people treated with either loop diuretic medication ...
November 8, 2022 — A single IV infusion of NTLA-2001, a novel CRISPR/Cas9-based gene editing therapy, significantly ...
November 8, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions ...